GB Patent

GB2018713A — Composite container

Assigned to OI Glass Inc · Expires 1979-10-24 · 47y expired

What this patent protects

A container comprises a tubular composite container body 12 closed at one end by a plastics end 14 which is compression-molded into bonded engagement with a composite can body. The plastics end is formed from the same plastics, e.g. polyethylene, as that which forms the inner lin…

USPTO Abstract

A container comprises a tubular composite container body 12 closed at one end by a plastics end 14 which is compression-molded into bonded engagement with a composite can body. The plastics end is formed from the same plastics, e.g. polyethylene, as that which forms the inner lining on the composite can body so as to form a leak-proof seal between the plastics end and the composite can body. The can body comprises a main body wall of paper layers, the inner lining, and an outer aluminium/paper label, and may be closed at its other end by a similar plastics end or a seamed-on metallic closure. <IMAGE>

Drugs covered by this patent

Patent Metadata

Patent number
GB2018713A
Jurisdiction
GB
Classification
Expires
1979-10-24
Drug substance claim
No
Drug product claim
No
Assignee
OI Glass Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.